Bayer AG
BAYRY · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -0.01 | 0.27 | -0.01 | 0.15 |
| FCF Yield | 2.22% | 2.36% | -6.42% | 21.05% |
| EV / EBITDA | 111.22 | 278.49 | 15.95 | 31.73 |
| Quality | ||||
| ROIC | 0.56% | 0.01% | 1.93% | 2.77% |
| Gross Margin | 55.41% | 59.36% | 59.06% | 51.21% |
| Cash Conversion Ratio | -1.66 | -5.57 | -0.78 | -15.23 |
| Growth | ||||
| Revenue 3-Year CAGR | -0.20% | -1.77% | -2.65% | -2.79% |
| Free Cash Flow Growth | 3.89% | 142.27% | -135.99% | 158.83% |
| Safety | ||||
| Net Debt / EBITDA | 65.42 | 171.82 | 9.86 | 20.65 |
| Interest Coverage | 0.74 | 0.02 | 3.98 | 9.17 |
| Efficiency | ||||
| Inventory Turnover | 0.35 | 0.36 | 0.44 | 0.43 |
| Cash Conversion Cycle | 225.47 | 247.78 | 197.09 | 168.47 |